Vinay Prasad named Chief Medical and Science Officer at USFDA: Report Ruchika Sharma20 Jun 2025 3:03 PM ISTBengaluru: The U.S. Food and Drug Administration (USFDA) top vaccine official, Vinay Prasad, has been appointed as the agency's new chief medical...
Sanofi Dupixent gets USFDA nod for bullous pemphigoid treatment in adults Written By Ruchika Sharma20 Jun 2025 12:15 PM ISTParis: Sanofi has received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the treatment of adult patients...
USFDA inspection: Natco Pharma gets 7 observations for Kothur Pharma Division Written By Ruchika Sharma20 Jun 2025 11:31 AM ISTHyderabad: Natco Pharma Limited has announced that the U.S. Food and Drug Administration (FDA) has concluded an inspection with seven...
CDSCO Panel Rejects Phase II Data for Reliance's RelCoVax COVID-19 Booster Over Immunogenicity Gap Written By Dr. Kamal Kant Kohli19 Jun 2025 7:53 PM ISTNew Delhi: The Subject Expert Committee (SEC) on COVID-19 vaccines, operating under the Central Drugs Standard Control Organisation (CDSCO), has...
Novo Nordisk Told to Increase Indian Patient Enrollment for Ziltivekimab Study Written By Dr. Divya Colin19 Jun 2025 7:36 PM ISTNew Delhi: In response to a proposal by Novo Nordisk, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO)...
Indian Pharma market sees 6.9% growth in May: Report Ruchika Sharma19 Jun 2025 3:00 PM ISTNew Delhi: The India pharmaceutical market (IPM) registered a 6.9 percent (on-year) growth in May, primarily propelled by strong performances in...
Morepen Labs incorporates wholly owned subsidiary in Dubai Ruchika Sharma19 Jun 2025 12:30 PM ISTGurugram: Morepen Labs has incorporated a wholly owned subsidiary, MOREPEN LABS - FZCO, in Dubai, United Arab Emirates.The new entity...
Gilead Sciences twice-yearly injection for HIV prevention bags USFDA okay Written By Ruchika Sharma19 Jun 2025 11:56 AM ISTFoster City: Gilead Sciences, Inc., a biopharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) for...
Marksans Pharma arm gets marketing authorization for Oxybutynin hydrochloride 2.5mg/5ml Oral Solution in UK Written By Ruchika Sharma19 Jun 2025 11:22 AM ISTMumbai: Marksans Pharma Limited, an Indian pharmaceutical company, has announced that its wholly owned subsidiary in the...
Zydus gets 2 USFDA observations for Ahmedabad oncology injectable site Written By Ruchika Sharma19 Jun 2025 10:54 AM ISTAhmedabad: Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) has issued two observations for the...
Phase 3 trial initiated for Ifinatamab Deruxtecan in Pretreated Metastatic Castration-Resistant Prostate Cancer: Merck, Daiichi Sankyo Written By Ruchika Sharma19 Jun 2025 10:00 AM ISTBasking Ridge: Merck and Daiichi Sankyo have announced that the first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating...
DoP extends deadline for submitting applications under PLI Scheme for pharma sector Written By Ruchika Sharma18 Jun 2025 5:45 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, has extended the deadline for submitting...
